Newsletter | January 30, 2025

Best of January: Top 5 Insights In Clinical Trial Technology

Clinical Tech Leader

TOP 5 INSIGHTS IN CLINICAL TRIAL TECHNOLOGY
JANUARY EDITION

#1 - Why Aren't We Using More Wearables In Clinical Trials?

Wearables provide a great means for passive data collection in clinical trials, but implementing them isn’t as easy at it seems. Lauren Sunshine of BMS talks about some of the advantages — and challenges — of incorporating DHTs into your trial protocols.

#2 - Electronic Hauser Diary For Parkinson's Clinical Trials

At the Movement Disorder Society International Congress 2024 in Philadelphia, Signant Health presented their latest research on an electronic Diary for Parkinson's disease used to assess the functional status of Parkinson’s disease patients.

#3 - 4 Perspectives On What's Next In Clinical Trial Tech

Clinical Leader asked clinical research professionals: “Internal, external, patient-facing, or otherwise — what clinical trial tech tool are you most excited to embrace or ditch in the new year? And why?”

#4 - QT Monitoring Impacts More Than Just Cardiac Health

QT monitoring is essential in clinical trials for assessing the cardiac safety of new drugs. Discover how to achieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.

#5 - 8 Essentials For Using DHTs In Clinical Trials

Planning to use some type of digital health technology (DHT) in clinical trials? Then be sure to check out these eight key takeaways from the FDA’s Digital Health Technologies for Remote Data Acquisition in Clinical Investigations Guidance.